
- Pharmaceutical Technology-10-02-2020
- Volume 44
- Issue 10
Automated Perfusion System
Cytiva announced that it is launching the Xcellerex Automated Perfusion System (APS), a device aimed at simplifying processes and reducing risks when intensifying upstream operations.
Cytiva announced that it is launching the Xcellerex Automated Perfusion System (APS), a device aimed at simplifying processes and reducing risks when intensifying upstream operations. Integrated with Cytiva’s Xcellerex XDR bioreactors, the APS system comes equipped with filter switching, liquid management, and cell bleed to reduce risk of human error and increase process robustness, a company press release said. The system also eliminates bottlenecks along the perfusion process, which increases productivity and output.
Articles in this issue
almost 6 years ago
Unique Molecules Push Formulation Boundariesalmost 6 years ago
Development of a Validated Method of Testing for NDMA in Ranitidinealmost 6 years ago
Masking Taste: A Key Attribute to Successalmost 6 years ago
Factoring Stability in the Biologic Drug Mixalmost 6 years ago
Improving Agility Through Scalabilityalmost 6 years ago
Modernizing Bioprocessing for Gene Therapy Viral Vectorsalmost 6 years ago
Scaling Up Fastalmost 6 years ago
Viewpoint: Digitizing Processes to Align with GMP Requirementsalmost 6 years ago
Unlocking the Key Changes to Annex 1almost 6 years ago
Strategizing for Rapid Changeovers in Biologics Manufacturing



